Author

Piyanuch Kongtim

University of California Irvine - Cited by 1,571 - Hematopoietic Stem Cell Transplantation

Biography

She is currently working in the   Department of Stem Cell Transplantation & Cellular Therapy University of Texas MD Anderson Cancer Center  in United States.She also worked as an faculty member in Thammasat University in Bankok.She completed MD in  hammasat University in Bankok.
Title
Cited by
Year
The European Society for Blood and Marrow Transplantation (EBMT) consensus guidelines for the detection and treatment of donor-specific anti-HLA antibodies (DSA) in …
SO Ciurea, K Cao, M Fernandez-Vina, P Kongtim, MA Malki, E Fuchs, ...Bone marrow transplantation 53 (5), 521-534, 2018201
184
2018
The European Society for Blood and Marrow Transplantation (EBMT) consensus recommendations for donor selection in haploidentical hematopoietic cell transplantation
SO Ciurea, MM Al Malki, P Kongtim, EJ Fuchs, L Luznik, XJ Huang, ...Bone marrow transplantation 55 (1), 12-24, 2020202
112
2020
Haploidentical transplantation for older patients with acute myeloid leukemia and myelodysplastic syndrome
SO Ciurea, MV Shah, RM Saliba, S Gaballa, P Kongtim, G Rondon, ...Biology of Blood and Marrow Transplantation 24 (6), 1232-1236, 2018201
62
2018
Clinical applications of donor lymphocyte infusion from an HLA-haploidentical donor: consensus recommendations from the Acute Leukemia Working Party of the EBMT
B Dholaria, BN Savani, M Labopin, L Luznik, A Ruggeri, S Mielke, ...haematologica 105 (1), 47, 2020202
55
2020
Is there an optimal conditioning for older patients with AML receiving allogeneic hematopoietic cell transplantation?
SO Ciurea, P Kongtim, A Varma, G Rondon, J Chen, S Srour, Q Bashir, ...Blood, The Journal of the American Society of Hematology 135 (6), 449-452, 2020202
40
2020
Decrease post-transplant relapse using donor-derived expanded NK-cells
SO Ciurea, P Kongtim, D Soebbing, P Trikha, G Behbehani, G Rondon, ...Leukemia 36 (1), 155-164, 2022202
38
2022
Relapse and survival after transplantation for complex karyotype acute myeloid leukemia: a report from the Acute Leukemia Working Party of the European Society for Blood and …
SO Ciurea, M Labopin, G Socie, L Volin, J Passweg, P Chevallier, ...Cancer 124 (10), 2134-2141, 2018201
33
2018
Is a matched unrelated donor search needed for all allogeneic transplant candidates?
SO Ciurea, MCB Bittencourt, DR Milton, K Cao, P Kongtim, G Rondon, ...Blood 132, 3450, 2018201
27
2018
Impact of a novel prognostic model, hematopoietic cell transplant-composite risk (HCT-CR), on allogeneic transplant outcomes in patients with acute myeloid leukemia and …
P Kongtim, S Parmar, DR Milton, JMR Perez, G Rondon, J Chen, ...Bone marrow transplantation 54 (6), 839-848, 2019201
26
2019
Treatment of allosensitized patients receiving allogeneic transplantation
SO Ciurea, MM Al Malki, P Kongtim, J Zou, FM Aung, G Rondon, J Chen, ...Blood advances 5 (20), 4031-4043, 2021202
24
2021
Haploidentical transplantation for acute myeloid leukemia patients with minimal/measurable residual disease at transplantation
SA Srour, RM Saliba, MCB Bittencourt, JMR Perez, P Kongtim, A Alousi, ...American journal of hematology 94 (12), 1382-1387, 191
20
2019
Who is the best donor for haploidentical stem cell transplantation?
P Kongtim, SO CiureaSeminars in hematology 56 (3), 194-200, 2019201
17
2019
Molecular disparity in human leukocyte antigens is associated with outcomes in haploidentical stem cell transplantation
J Zou, SO Ciurea, P Kongtim, M Yi, Y Carmazzi, G Rondon, S Srour, ...Blood advances 4 (15), 3474-3485, 2020202
13
2020
Novel disease risk model for patients with acute myeloid leukemia receiving allogeneic hematopoietic cell transplantation
P Kongtim, O Hasan, JMR Perez, A Varma, SA Wang, KP Patel, J Chen, ...Biology of Blood and Marrow Transplantation 26 (1), 197-203, 2020202
13
2020
Optimizing the conditioning regimen for hematopoietic cell transplant in myelofibrosis: long-term results of a prospective phase II clinical trial
U Popat, RS Mehta, R Bassett, P Kongtim, J Chen, AM Alousi, P Anderlini, ...Biology of Blood and Marrow Transplantation 26 (8), 1439-1445, 2020202
12
2020
Validation of a hematopoietic cell transplant-composite risk (HCT-CR) model for post-transplant survival prediction in patients with hematologic malignancies
SO Ciurea, P Kongtim, O Hasan, JM Ramos Perez, J Torres, G Rondon, ...Clinical Cancer Research 26 (10), 2404-2410, 2020202
8
2020
Haploidentical transplants for patients with relapse after the first allograft
SA Srour, P Kongtim, G Rondon, J Chen, D Petropoulos, J Ramdial, ...American journal of hematology 95 (10), 117-1192, 2020202
8
2020
Correction: The European Society for Blood and Marrow Transplantation (EBMT) Consensus Guidelines for the Detection and Treatment of Donor-specific Anti-HLA Antibodies (DSA) in …
SO Ciurea, K Cao, M Fernandez-Vina, P Kongtim, MA Malki, E Fuchs, ...Bone marrow transplantation 4 (), 784-784, 2019201
5
2019
Refined HLA-DPB1 mismatch with molecular algorithms predicts outcomes in hematopoietic stem cell transplantation
J Zou, P Kongtim, B Oran, V Kosmoliaptsis, Y Carmazzi, J Ma, L Li, ...haematologica 107 (4), 844, 2022202
5
2022
Haploidentical transplants for patients with graft failure after the first allograft
P Kongtim, M Bittencourt, SA Srour, J Ramdial, G Rondon, J Chen, ...Am J Hematol 95 (10), E267-E269, 2020202
4
2020

Referred From: https://scholar.google.co.th/citations?user=uKVBN38AAAAJ&hl=th

Cited by
Citations 1571
h-index 20
i10-index 27
Recommended Journals
Open Access Journals